Combination Drugs
- All
- News
- Videos
-
People Using AI Chatbots As Tripsitter When Using Psychedelics, Sparking Concerns
Trip sitter is a phrase that traditionally refers to a sober person tasked with monitoring someone who's under the influence of a psychedelic.
-
Anti-Ageing Drug Combo Extends Mouse Lifespan By 30%, Sparks Hope For Human Longevity
A study by the Max Planck Institute found that combining rapamycin and trametinib extended mice lifespans by up to 30%, offering promising insights into potential human anti-aging therapies.
-
Torn Notes, Apps: How Cartel Behind Delhi's Biggest Drug Bust Mixed Low And High Tech
The cartel behind Delhi's biggest drug busts totalling over Rs 7,000 crore combined low-tech methods as well as modern ones to avoid detection and ensure the consignments reached the intended recipients.
-
Centre Bans 156 Combination Medicines Used For Fever, Pain, Cold
The government has banned 156 widely sold fixed-dose combination (FDC) drugs including antibacterial medicines used for fever, cold, allergies and pain, saying that they are "likely to involve risk to human beings".
-
India Bans Anti-Cold Drug For Children Below 4 After Syrup Deaths Claim
The drugs regulator in India has banned the use of an anti-cold drug combination in children aged below four and ordered that drugs should be labelled accordingly, in the wake of the deaths of at least 141 children globally linked to cough syrups.
-
Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years
The Central Drugs Standard Control Organisation (CDSCO) has prohibited the use of anti-cold fixed drug combinations in children below four years of age.
-
"Risk To Human Beings": Government Bans 14 Fixed-Dose Combination Drugs
The government has banned 14 fixed dose combination drugs including Nimesulide and Paracetamol dispersible tablets and Chlopheniramine Maleate and Codeine syrup citing there is "no therapeutic justification" for these medicines.
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
New Drug Combination Found Effective Against COVID-19 Infection: Study
A new drug combination can suppress infection by the S-CoV-2 virus, which causes COVID-19, according to a study conducted in animals and cell cultures.
-
Smartphone Sensor Data Could Determine Cannabis Intoxication With 90 Percent Accuracy: StudyÂ
New research says that smartphone sensors can be used to detect cannabis intoxication. The research, by Rutgers Institute for Health, Health Care Policy and Aging Research, was published in the Drug and Alcohol Dependence journal.
-
Masks Will Stay Through 2022, Need Drug Against Covid: NITI Aayog Member
Dr VK Paul, the NITI Aayog Member for Health, said battling Covid will require a combination of vaccines, effective drugs, and disciplined social behaviour. He did not ruling out a third wave and cautioned against the risky festival lying ahead.
-
Cambridge University Researchers Use AI to Find 200 Drugs For COVID Treatment
Researchers at Cambridge University combined computational biology and machine learning to study proteins linked to COVID-19, and then studied 2,000 drugs to find suitable treatments, coming up with a list of 200 possibilities.
-
4 New Units To Manufacture 700 Million Vaccine Doses A Year: Bharat Biotech
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, today said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per year.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
-
People Using AI Chatbots As Tripsitter When Using Psychedelics, Sparking Concerns
Trip sitter is a phrase that traditionally refers to a sober person tasked with monitoring someone who's under the influence of a psychedelic.
-
Anti-Ageing Drug Combo Extends Mouse Lifespan By 30%, Sparks Hope For Human Longevity
A study by the Max Planck Institute found that combining rapamycin and trametinib extended mice lifespans by up to 30%, offering promising insights into potential human anti-aging therapies.
-
Torn Notes, Apps: How Cartel Behind Delhi's Biggest Drug Bust Mixed Low And High Tech
The cartel behind Delhi's biggest drug busts totalling over Rs 7,000 crore combined low-tech methods as well as modern ones to avoid detection and ensure the consignments reached the intended recipients.
-
Centre Bans 156 Combination Medicines Used For Fever, Pain, Cold
The government has banned 156 widely sold fixed-dose combination (FDC) drugs including antibacterial medicines used for fever, cold, allergies and pain, saying that they are "likely to involve risk to human beings".
-
India Bans Anti-Cold Drug For Children Below 4 After Syrup Deaths Claim
The drugs regulator in India has banned the use of an anti-cold drug combination in children aged below four and ordered that drugs should be labelled accordingly, in the wake of the deaths of at least 141 children globally linked to cough syrups.
-
Centre Bans Anti-Cold Fixed Drug Combination In Children Below 4 Years
The Central Drugs Standard Control Organisation (CDSCO) has prohibited the use of anti-cold fixed drug combinations in children below four years of age.
-
"Risk To Human Beings": Government Bans 14 Fixed-Dose Combination Drugs
The government has banned 14 fixed dose combination drugs including Nimesulide and Paracetamol dispersible tablets and Chlopheniramine Maleate and Codeine syrup citing there is "no therapeutic justification" for these medicines.
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
New Drug Combination Found Effective Against COVID-19 Infection: Study
A new drug combination can suppress infection by the S-CoV-2 virus, which causes COVID-19, according to a study conducted in animals and cell cultures.
-
Smartphone Sensor Data Could Determine Cannabis Intoxication With 90 Percent Accuracy: StudyÂ
New research says that smartphone sensors can be used to detect cannabis intoxication. The research, by Rutgers Institute for Health, Health Care Policy and Aging Research, was published in the Drug and Alcohol Dependence journal.
-
Masks Will Stay Through 2022, Need Drug Against Covid: NITI Aayog Member
Dr VK Paul, the NITI Aayog Member for Health, said battling Covid will require a combination of vaccines, effective drugs, and disciplined social behaviour. He did not ruling out a third wave and cautioned against the risky festival lying ahead.
-
Cambridge University Researchers Use AI to Find 200 Drugs For COVID Treatment
Researchers at Cambridge University combined computational biology and machine learning to study proteins linked to COVID-19, and then studied 2,000 drugs to find suitable treatments, coming up with a list of 200 possibilities.
-
4 New Units To Manufacture 700 Million Vaccine Doses A Year: Bharat Biotech
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, today said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per year.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
